Trials / Completed
CompletedNCT00004936
MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients
Role of Radiology in the Pretreatment Evaluation of Invasive Cervical Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- American College of Radiology Imaging Network · Network
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients.
Detailed description
OBJECTIVES: * Compare the diagnostic performance of magnetic resonance imaging (MRI), computed tomography (CT), and clinical FIGO staging in patients with invasive cervical cancer. * Compare the accuracy of MRI, CT, and clinical FIGO staging in the evaluation of morphologic tumor prognostic factors in FIGO stage IB1 and stage IB2 and greater in these patients. * Examine the value of imaging assessment of tumor prognostic factors (alone or in combination) as predictors of recurrence within 2 years of surgery in these patients. * Evaluate the quality of life in the 12-month period after staging and treatment to potentially change staging accuracy. OUTLINE: This is a multicenter study. Patients undergo a computed tomography scan with iodinated contrast dye followed by a magnetic resonance imaging scan with or without contrast comprising gadopentetate dimeglumine or vice versa. Within 6 weeks of first protocol imaging study, patients undergo one of the following surgeries: * Laparoscopic, transabdominal, or transvaginal hysterectomy * Extrafascial total abdominal hysterectomy * Trachelectomy Quality of life is assessed at 1 and 12 months. Patients are followed every 3 months for 1 year and then every 6 months for 1 year. PROJECTED ACCRUAL: A total of 465 patients will be accrued for this study within 18 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | iodinated contrast dye | |
| PROCEDURE | computed tomography | |
| PROCEDURE | magnetic resonance imaging | |
| RADIATION | gadopentetate dimeglumine |
Timeline
- Start date
- 2000-04-01
- Primary completion
- 2001-05-01
- Completion
- 2002-10-01
- First posted
- 2003-01-27
- Last updated
- 2013-01-28
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00004936. Inclusion in this directory is not an endorsement.